IJSMT Journal

International Journal of Science, Strategic Management and Technology

EdTech Publishers (OPC) Private Limited

Announcements

  • Call for Papers
    IJSMT invites researchers, academicians, and professionals to submit original manuscripts for upcoming issues and contribute to advancing scientific and technological knowledge.
  • New Issue Release
    The next issue of IJSMT is scheduled for publication soon. Accepted papers will receive DOI and certificate of publication.
  • Editorial Board Membership
    Applications are open for qualified academicians and researchers to join as Editorial Board Members or Reviewers.
  • Indexing and Recognition
    IJSMT is continuously working toward inclusion in reputed academic databases to enhance global visibility and citation impact.
  • Double-Blind Peer Review
    Each paper is evaluated by qualified reviewers to ensure fairness, credibility, and academic excellence.
  • Open Access Policy
    All published articles in IJSMT are freely accessible online to promote wider dissemination and accessibility of research findings.

Advancements in CRISPR Gene Editing: Applications and Ethical Considerations

 

Divya Sree¹, Mohammed Arif², Keerthana P.³

¹ Department of Biotechnology, School of Engineering, Anurag University, Hyderabad, Telangana, India
² Department of Biotechnology, School of Engineering, Anurag University, Hyderabad, Telangana, India
³ Department of Biotechnology, School of Engineering, Anurag University, Hyderabad, Telangana, India

 

 

Abstract

CRISPR-Cas9, a revolutionary genome-editing technology, has transformed molecular biology with its precision, efficiency, and versatility. This article explores recent advancements in CRISPR-based systems, including novel Cas proteins, base editing, and prime editing, and their applications in medicine, agriculture, and environmental sciences. We review key developments, such as therapeutic interventions for genetic disorders and cancer, as well as agricultural enhancements for crop resilience. Ethical considerations, particularly surrounding human germline editing, off-target effects, and equitable access, are critically analyzed. Through a comprehensive literature review and discussion of current methodologies, this article evaluates the potential and challenges of CRISPR technologies. We conclude with insights into future directions, emphasizing the need for robust regulatory frameworks and inclusive ethical discussions to ensure responsible use.CRISPR-Cas9 technology has revolutionized genome editing, offering unprecedented precision and efficiency in modifying genetic material. Recent advancements have expanded the CRISPR toolkit, introducing novel Cas proteins with enhanced specificity and reduced off-target effects. Base editing and prime editing techniques have further refined the technology, allowing for more precise genetic modifications without inducing double-strand breaks. These innovations have opened new avenues in medicine, agriculture, and environmental sciences, enabling targeted therapeutic interventions for genetic disorders and cancer, as well as the development of crops with improved resilience to environmental stresses.

Agricultural applications focus on developing crops with improved yield, nutritional content, and resistance to pests and environmental stresses. Environmental scientists are exploring CRISPR’s potential in conservation efforts and managing invasive species. However, these advancements are accompanied by ethical concerns, particularly regarding human germline editing, potential off-target effects, and equitable access to the technology. As CRISPR continues to evolve, addressing these ethical considerations and establishing robust regulatory frameworks will be crucial to ensure responsible development and application of this powerful technology.

Keywords

CRISPR-Cas9, genome editing, gene therapy, ethical considerations, somatic editing, germline editing, off-target effects, precision medicine, agriculture, healjth equity

 

References

  1. Wang, H., & Doudna, J. A. (2023). CRISPR technology: A decade of genome editing is only the beginning. Science, 379(6629), 355-360.
  2. Levesque, S., & Bauer, D. E. (2025). CRISPR-based therapeutic genome editing for inherited blood disorders. Nature Reviews Drug Discovery.
  3. Liang, Y., et al. (2025). Expanding horizons of CRISPR applications beyond genome editing. Trends in Genetics.
  4. Hildebrandt, C. C., & Marron, J. M. (2018). Justice in CRISPR/Cas9 research and clinical applications. AMA Journal of Ethics, 20(9), E826-833.
  5. Shinwari, Z. K., Tanveer, F., & Khalil, A. T. (2018). Ethical issues regarding CRISPR mediated genome editing. Current Issues in Molecular Biology, 26, 103-110.
  6. Greely, H. T. (2019). CRISPR’d babies: Human germline genome editing in the He Jiankui affair. Journal of Law and the Biosciences, 6(1), 111-183.
  7. Cathomen, T., et al. (2019). Ethical and regulatory challenges in genome editing. Nature Reviews Genetics, 20(2), 87-98.

 

Call for Papers
Volume 01 Issue 01 October 2025
Submission
Last Date
31/10/2025
Acceptance
Status
within 6 Days
Paper Publish within 5 Days
Scroll to Top